Literature DB >> 21127188

Competing cell clones in myeloproliferative neoplasm.

Aref Al-Kali, Srdan Verstovsek, Hagop Kantarjian, Rajyalakshmi Luthra, Jorge Cortes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 21127188      PMCID： PMC4916558          DOI： 10.1182/blood-2010-05-284885

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  10 in total

1.  Myelofibrosis evolving during imatinib treatment of a chronic myeloproliferative disease with coexisting BCR-ABL translocation and JAK2V617F mutation.

Authors:  Kais Hussein; Oliver Bock; Anna Seegers; Michael Flasshove; Felicitas Henneke; Guntram Buesche; Hans Heinrich Kreipe
Journal:  Blood       Date:  2007-05-01       Impact factor: 22.113

2.  Analyses of TET2 mutations in post-myeloproliferative neoplasm acute myeloid leukemias.

Authors:  L Couronné; E Lippert; J Andrieux; O Kosmider; I Radford-Weiss; D Penther; N Dastugue; F Mugneret; M Lafage; N Gachard; N Nadal; O A Bernard; F Nguyen-Khac
Journal:  Leukemia       Date:  2009-08-27       Impact factor: 11.528

3.  Mutations of ASXL1 gene in myeloproliferative neoplasms.

Authors:  N Carbuccia; A Murati; V Trouplin; M Brecqueville; J Adélaïde; J Rey; W Vainchenker; O A Bernard; M Chaffanet; N Vey; D Birnbaum; M J Mozziconacci
Journal:  Leukemia       Date:  2009-07-16       Impact factor: 11.528

4.  A unique clonal JAK2 mutation leading to constitutive signalling causes polycythaemia vera.

Authors:  Chloé James; Valérie Ugo; Jean-Pierre Le Couédic; Judith Staerk; François Delhommeau; Catherine Lacout; Loïc Garçon; Hana Raslova; Roland Berger; Annelise Bennaceur-Griscelli; Jean Luc Villeval; Stefan N Constantinescu; Nicole Casadevall; William Vainchenker
Journal:  Nature       Date:  2005-04-28       Impact factor: 49.962

5.  Acute leukemia in polycythemia vera: an analysis of 1638 patients enrolled in a prospective observational study.

Authors:  Guido Finazzi; Vanesa Caruso; Roberto Marchioli; Giovanni Capnist; Teodoro Chisesi; Carlo Finelli; Luigi Gugliotta; Raffaele Landolfi; Jack Kutti; Heinz Gisslinger; Raphael Marilus; Carlo Patrono; Enrico Maria Pogliani; Maria Luigia Randi; Ana Villegas; Gianni Tognoni; Tiziano Barbui
Journal:  Blood       Date:  2004-12-07       Impact factor: 22.113

6.  Two routes to leukemic transformation after a JAK2 mutation-positive myeloproliferative neoplasm.

Authors:  Philip A Beer; François Delhommeau; Jean-Pierre LeCouédic; Mark A Dawson; Edwin Chen; David Bareford; Rajko Kusec; Mary Frances McMullin; Claire N Harrison; Alessandro M Vannucchi; William Vainchenker; Anthony R Green
Journal:  Blood       Date:  2009-12-11       Impact factor: 22.113

7.  AML1/RUNX1 point mutation possibly promotes leukemic transformation in myeloproliferative neoplasms.

Authors:  Ye Ding; Yuka Harada; Jun Imagawa; Akiro Kimura; Hironori Harada
Journal:  Blood       Date:  2009-12-10       Impact factor: 22.113

8.  Genetic analysis of transforming events that convert chronic myeloproliferative neoplasms to leukemias.

Authors:  Omar Abdel-Wahab; Taghi Manshouri; Jay Patel; Kelly Harris; Jinjuan Yao; Cyrus Hedvat; Adriana Heguy; Carlos Bueso-Ramos; Hagop Kantarjian; Ross L Levine; Srdan Verstovsek
Journal:  Cancer Res       Date:  2010-01-12       Impact factor: 12.701

9.  Leukemic blasts in transformed JAK2-V617F-positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.

Authors:  Alexandre Theocharides; Marjorie Boissinot; François Girodon; Richard Garand; Soon-Siong Teo; Eric Lippert; Pascaline Talmant; Andre Tichelli; Sylvie Hermouet; Radek C Skoda
Journal:  Blood       Date:  2007-03-15       Impact factor: 22.113

10.  IDH1 and IDH2 mutation analysis in chronic- and blast-phase myeloproliferative neoplasms.

Authors:  A Pardanani; T L Lasho; C M Finke; M Mai; R F McClure; A Tefferi
Journal:  Leukemia       Date:  2010-04-22       Impact factor: 12.883
  10 in total
  1 in total

1.  An Polycythemia Vera Evolve from Acute Myeloid Leukemia? Report of a Case Showing a Simultaneous Minor JAK2 V617F Mutated Clone.

Authors:  Beatrice Borsellino; Arianna Savi; Maria Rosaria Pascale; Elisa Meddi; Maria Ilaria Del Principe; Antonio Cristiano; Tiziana Ottone; Maria Cristina Rapanotti; Mariadomenica Divona; Serena Travaglini; Enrico Attardi; Raffaele Palmieri; Elisa Buzzatti; Francesco Buccisano; Maria Teresa Voso
Journal:  Mediterr J Hematol Infect Dis       Date:  2022-07-01       Impact factor: 3.122
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.